Skip to content

Investigating Management, Perspectives and Attitudes Towards Care in Takayasu Arteritis

Investigating Management, Perspectives and Attitudes Towards Care in Takayasu Arteritis

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT07351422
Acronym
TAK-IMPACT
Enrollment
50
Registered
2026-01-20
Start date
2025-10-01
Completion date
2027-03-15
Last updated
2026-01-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Takayasu Arteritis, Takayasu Arteritis (TAK)

Brief summary

This study aims to understand the experiences of patients with Takayasu arteritis (TAK) and how physicians manage the condition. To achieve this, two separate questionnaires will be conducted: one for patients and one for physicians.

Detailed description

This study aims to investigate the experiences and perceptions of patients with Takayasu arteritis regarding their disease, as well as the perspectives of physicians regarding the management and treatment of these patients. Patients with TAK will be invited to complete an anonymous online (Online Surveys) questionnaire, which will take approximately 25 minutes and will consist of multiple-choice and short-answer questions. The questionnaire will ask about their experience with the condition, symptoms, treatments they have received, and any concerns or priorities they have regarding their care. Physicians who treat TAK will also be invited to complete a separate online questionnaire, taking around 15 minutes and also consisting of multiple-choice and short-answer questions. This will explore how they diagnose and manage TAK, their choice of treatments, and any challenges they face in treating the condition

Interventions

OTHERQuestionnaire

An online annoymous questionnaire consisting of short-answer and multiple-choice questions

Sponsors

University of Edinburgh
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

For the patient questionnaire: * Age ≥ 18 years * A formal diagnosis of TAK For the physician questionnaire • A physician involved in the management/decision-making for patients diagnosed with TAK

Exclusion criteria

For the patient questionnaire: * Age \< 18 years * Lack of a formal diagnosis of TAK * Patients without mental capacity or willingness to provide informed consent * Not UK based For the physician questionnaire * Not involved in the management/ decision making for patients diagnosed with TAK * Not willing to take part * Not UK based

Design outcomes

Primary

MeasureTime frameDescription
Patient PerspectiveDay 1To understand the lived experiences of individuals with TAK, including their symptoms, health status post-diagnosis, treatment priorities, and concerns. The questionnaire covers the following topics: * Basic background information * Living with Takayasu arteritis * Changes to health since diagnosis * Physical activity and exercise habits- measured by the International Physical Activity Questionnaire (IPAQ) * Smoking history * Mental well-being- measured by the EQ-5D instrument * Nutrition and diet * Personal views and priorities on management
Physician PerspectiveDay 1To evaluate current clinical management strategies for TAK, identify treatment priorities, and highlight areas of unmet need in clinical practice. The physician questionnaire covers the following topics: * Clinical background and experience with TAK patients * Diagnostic and treatment strategies for TAK * Consideration of cardiovascular disease risk in TAK management * Physician priorities and unmet needs of management

Countries

United Kingdom

Contacts

CONTACTAlexandra Armstrong
A.Armstrong-9@sms.ed.ac.uk+447445695898

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026